Toll Free: 1-888-928-9744

United States Radiopharmaceutical Industry 2017 Market Research Report

Published: Apr, 2017 | Pages: 144 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In the last several years, United States market of radiopharmaceuticals developed smoothly, with an average growth rate of 7.6%. In 2016, United States revenue of radiopharmaceuticals is nearly 1.7 billion USD.

In the future, United States market is expected to witness significant growth on account of rising cancer and cancer patients, so in the next few years, radiopharmaceuticals revenue will show a trend of steady growth. In 2022 the revenue of radiopharmaceuticals is estimated to be 2.4 billion USD. 

The major players in United States Radiopharmaceuticals market include 

•	Bayer
•	Triad Isotopes
•	Lantheus
•	GE Healthcare
•	Mallinckrodt
•	Eli Lilly
•	Bracco Imaging
•	SIEMENS
•	Navidea
•	Nordion
•	IBA Group
•	Jubilant Pharma

On the basis of product, the Radiopharmaceuticals market is primarily split into 

•	Diagnostic Radioisotopes
•	Therapeutic Radioisotopes

On the basis on the applications, this report covers

•	Oncology
•	Cardiology
•	Other
 Table of Contents

1 Industry Overview	1
1.1 Definition and Specifications of Radiopharmaceuticals	1
1.1.1 Definition of Radiopharmaceuticals	1
1.1.2 Specifications of Radiopharmaceuticals	1
1.2 Classification of Radiopharmaceuticals	3
1.2.1 Diagnostic Radioisotopes	4
1.2.2 Therapeutic Radioisotopes	5
1.3 Applications of Radiopharmaceuticals	5
1.3.1 Oncology	7
1.3.2 Cardiology	7
1.3.3 Other	8
1.4 Industry Chain Structure of Radiopharmaceuticals	9
1.5 Industry Regional Overview of Radiopharmaceuticals	10
1.6 Industry Policy Analysis of Radiopharmaceuticals	11
1.7 Industry News Analysis of Radiopharmaceuticals	12

2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals	15
2.1 Raw Material and Suppliers	15
2.2 Equipment Suppliers Analysis of Radiopharmaceuticals	15
2.3 Labor Cost Analysis of Radiopharmaceuticals	16
2.4 Other Costs Analysis	18
2.4.1 USA Cost of Electricity Analysis	18
2.4.2 USA Water Cost Analysis	18
2.5 Manufacturing Cost Structure Analysis of Radiopharmaceuticals	19
2.6 Manufacturing Process Analysis of Radiopharmaceuticals	20
2.7 United States Price, Cost and Gross of Radiopharmaceuticals 2012-2017	21

3 Technical Data and Manufacturing Plants Analysis of Radiopharmaceuticals	23
3.1 Capacity and Established Date of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016	23
3.2 Headquarter of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016	23
3.3 R&D Status/Revenue and Sales Region of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016	24

4 Production Analysis of Radiopharmaceuticals by Regions, Technology, and Applications	25
4.1 United States Production of Radiopharmaceuticals by Regions 2012-2017	25
4.2 United States Production of Radiopharmaceuticals by Product Types 2012-2017	29
4.3 United States Sales of Radiopharmaceuticals by Applications 2012-2017	32
4.4 Price Analysis of United States Radiopharmaceuticals Key Manufacturers in 2016	36
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Radiopharmaceuticals 2012-2017	36

5 Consumption Volume and Consumption Value Analysis of Radiopharmaceuticals by Regions	38
5.1 United States Consumption Volume of Radiopharmaceuticals by Regions 2012-2017	38
5.2 United States Consumption Value of Radiopharmaceuticals by Regions 2012-2017	42
5.3 United States Consumption Price Analysis of Radiopharmaceuticals by Regions 2012-2017	46

6 Analysis of Radiopharmaceuticals Production, Supply, Sales and Market Status 2012-2017	47
6.1 Capacity, Production, Sales, and Revenue of Radiopharmaceuticals 2012-2017	47
6.2 Production Market Share and Sales Market Share of Radiopharmaceuticals 2012-2017	53
6.3 Sales Overview of Radiopharmaceuticals 2012-2017	60
6.4 Supply, Consumption and Gap of Radiopharmaceuticals 2012-2017	61
6.5 Import, Export and Consumption of Radiopharmaceuticals 2012-2017	62
6.6 Cost, Price, Revenue and Gross Margin of Radiopharmaceuticals 2012-2017	62

7 Major Manufacturers Analysis of Radiopharmaceuticals	64
7.1 Bayer	64
7.1.1 Company Profile	64
7.1.2 Product Information	65
7.1.3 Production, Price, Cost, Gross, and Revenue	65
7.2 Triad Isotopes	67
7.2.1 Company Profile	67
7.2.2 Product Information	68
7.2.3 Production, Price, Cost, Gross, and Revenue	68
7.3 Lantheus Medical Imaging	70
7.3.1 Company Profile	70
7.3.2 Product Information	71
7.3.3 Production, Price, Cost, Gross, and Revenue	71
7.4 GE Healthcare	73
7.4.1 Company Profile	73
7.4.2 Product Information	74
7.4.3 Production, Price, Cost, Gross, and Revenue	74
7.5 Mallinckrodt	76
7.5.1 Company Profile	76
7.5.2 Product Information	77
7.5.3 Production, Price, Cost, Gross, and Revenue	77
7.6 Eli Lilly	79
7.6.1 Company Profile	79
7.6.2 Product Information	80
7.6.3 Production, Price, Cost, Gross, and Revenue	80
7.7 Bracco Imaging	82
7.7.1 Company Profile	82
7.7.2 Product Information	83
7.7.3 Production, Price, Cost, Gross, and Revenue	84
7.8 SIEMENS	85
7.8.1 Company Profile	85
7.8.2 Product Information	87
7.8.3 Production, Price, Cost, Gross, and Revenue	87
7.9 Navidea	89
7.9.1 Company Profile	89
7.9.2 Product Information	90
7.9.3 Production, Price, Cost, Gross, and Revenue	90
7.10 Nordion	92
7.10.1 Company Profile	92
7.10.2 Product Information	93
7.10.3 Sales and Market Share	93
7.11 IBA Group	94
7.11.1 Company Profile	94
7.11.2 Product Information	95
7.11.3 Sales and Market Share	96
7.12 Jubilant Pharma	97
7.12.1 Company Profile	97
7.12.2 Product Information	98
7.12.3 Sales and Market Share	99

8 Price and Gross Margin Analysis	101
8.1 Analysis of Price	101
8.2 Gross Margin Analysis	101
8.3 Sales Price Comparison by Regions	102
8.4 Price Analysis of Different Radiopharmaceuticals Product Types	102
8.5 Gross Margin Analysis of Different Radiopharmaceuticals Applications	103

9 Marketing Trader or Distributor Analysis of Radiopharmaceuticals	104
9.1 Marketing Channels Status of Radiopharmaceuticals	104
9.2 Traders or Distributors of Radiopharmaceuticals with Contact Information	105
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Radiopharmaceuticals	106
9.4 United States Import, Export Analysis of Radiopharmaceuticals	106

10 Development Trend of Radiopharmaceuticals Industry 2017-2022	107
10.1 Capacity and Production Overview of Radiopharmaceuticals 2017-2022	107
10.2 Production Market Share by Product Types of Radiopharmaceuticals 2017-2022	108
10.3 Sales and Sales Revenue Overview of Radiopharmaceuticals 2017-2022	111
10.4 United States Sales of Radiopharmaceuticals by Applications 2017-2022	112
10.5 Import, Export and Consumption of Radiopharmaceuticals 2017-2022	113
10.6 Cost, Price, Revenue and Gross Margin of Radiopharmaceuticals 2017-2022	114

11 Industry Chain Suppliers of Radiopharmaceutical with Contact Information	115
11.1 Major Raw Materials Suppliers of Radiopharmaceutical with Contact Information	115
11.2 Manufacturing Equipment Suppliers of Radiopharmaceutical with Contact Information	116
11.3 Major Suppliers of Radiopharmaceuticals with Contact Information	116
11.4 Key Consumers of Radiopharmaceuticals with Contact Information	118
11.5 Supply Chain Relationship Analysis of Radiopharmaceutical	119

12 New Project Investment Feasibility Analysis of Radiopharmaceuticals	120
12.1 New Project SWOT Analysis of Radiopharmaceuticals	120
12.2 New Project Investment Feasibility Analysis of Radiopharmaceuticals	120
12.2.1 Project Name	120
12.2.2 Investment Budget	121
12.2.3 Project Product Solutions	121
12.2.4 Project Schedule	121

13 Conclusion of the United States Radiopharmaceutical Industry 2017 Market Research Report	123

14 Appendix	124
14.1 Methodology/Research Approach	124
14.1.1 Research Programs/Design	124
14.1.2 Market Size Estimation	125
14.1.3 Market Breakdown and Data Triangulation	126
14.2 Data Source	127
14.2.1 Secondary Sources	127
14.2.2 Primary Sources	128
14.3 Disclaimer	129
14.4 Author List	130

Tables and Figures

Figure Picture of Radiopharmaceuticals	1
Table Specifications of Radiopharmaceuticals	1
Table Specifications of Technetium-99m	2
Table Classification of Radiopharmaceuticals	3
Figure United States Production Market Share of Radiopharmaceuticals by Type in 2016	4
Figure Diagnostic Radioisotopes Picture	4
Table Diagnostic Nuclear Medicine / Radiopharmaceuticals Types	5
Figure Therapeutic Radioisotopes Picture	5
Table Application Fields of Radiopharmaceuticals Products	5
Figure 2016 United States Radiopharmaceuticals Major Applications Sales Share	6
Figure Oncology Examples	7
Figure Cardiology Examples	7
Figure Other Examples	8
Figure Industry Chain Structure of Radiopharmaceuticals	9
Figure United States Production Market Share of Radiopharmaceuticals by Region in 2016	10
Figure United States Sales Market Share of Radiopharmaceuticals by Region in 2016	11
Table FDA-approved Radiopharmaceuticals	11
Table Industry News List of Radiopharmaceuticals	12
Table Production Base and Market Concentration Rate of Raw Material	15
Table Equipment Suppliers Analysis of Radiopharmaceuticals	15
Figure USA Labor Cost Analysis	16
Figure Cost of Employing a Factory Worker	17
Table Average Price of Electricity to Ultimate Customers 2007-2016	18
Table Manufacturing Cost Structure Analysis of Radiopharmaceuticals in 2016	19
Figure Manufacturing Process Analysis of Radiopharmaceuticals	20
Figure United States Price Analysis of Radiopharmaceuticals 2012-2017 (USD/Dose)	21
Figure United States Cost Analysis of Radiopharmaceuticals 2012-2017 (USD/Dose)	21
Figure United States Gross Analysis of Radiopharmaceuticals 2012-2017	22
Table Capacity (M Doses) and Established Date of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016	23
Table Headquarter of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016	23
Table R&D Status/Revenue and Sales Region of Unites Stated Radiopharmaceuticals Major Manufacturers in 2016	24
Table United States Production of Radiopharmaceuticals by Regions 2012-2017 (M Doses)	25
Table United States Production Market Share of Radiopharmaceuticals by Regions 2012-2017	25
Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2012	26
Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2013	26
Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2014	27
Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2015	27
Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2016	28
Figure United States Production Market Share of Radiopharmaceuticals by Regions in 2017	28
Table United States Production of Radiopharmaceuticals by Product Types in 2012-2017 (M Doses)	29
Table United States Production Market Share of Radiopharmaceuticals by Product Types in 2012-2017	29
Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2012	29
Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2013	30
Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2014	30
Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2015	31
Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2016	31
Figure United States Production Market Share of Radiopharmaceuticals by Technology in 2017	32
Table United States Sales of Radiopharmaceuticals by Applications 2012-2017 (M Doses)	32
Table United States Production Market Share of Radiopharmaceuticals by Applications 2012-2017	32
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2012	33
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2013	33
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2014	34
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2015	34
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2016	35
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2017	35
Figure Price Comparison of United States Radiopharmaceuticals Key Manufacturers in 2016 (USD/Dose)	36
Table United States Capacity, Production, Import Export Sales Price, Cost and Revenue of Radiopharmaceuticals 2012-2017	36
Table United States Consumption Volume of Radiopharmaceuticals by Regions 2012-2017 (M Doses)	38
Table United States Consumption Volume Market Share of Radiopharmaceuticals by Regions 2012-2017	38
Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2012	39
Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2013	39
Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2014	40
Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2015	40
Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2016	41
Figure United States Consumption Volume Market Share of Radiopharmaceuticals by Regions in 2017	41
Table United States Consumption Value of Radiopharmaceuticals by Regions 2012-2017 (M USD)	42
Table United States Consumption Value Market Share of Radiopharmaceuticals by Regions 2012-2017	42
Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2012	43
Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2013	43
Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2014	44
Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2015	44
Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2016	45
Figure United States Consumption Value Market Share of Radiopharmaceuticals by Regions in 2017	45
Table Consumption Price of Radiopharmaceuticals by Regions 2012-2017 (USD/Dose)	46
Table United States and Major Manufacturers Capacity of Radiopharmaceuticals 2012-2017 (M Doses)	47
Table United States Capacity Market Share of Major Radiopharmaceuticals Manufacturers 2012-2017	47
Table United States and Major Manufacturers Production of Radiopharmaceuticals 2012-2017 (M Doses)	48
Table United States Production Market Share of Major Radiopharmaceuticals Manufacturers 2012-2017	48
Table United States and Major Manufacturers Sales of Radiopharmaceuticals 2012-2017 (M Doses)	49
Table United States Sales Market Share of Major Radiopharmaceuticals Manufacturers 2012-2017	49
Table United States and Major Manufacturers Revenue of Radiopharmaceuticals 2012-2017 (M USD)	50
Table United States Revenue Market Share of Major Radiopharmaceuticals Manufacturers 2012-2017	50
Figure United States Capacity (M Doses), Production (M Doses) and Growth Rate of Radiopharmaceuticals 2012-2017	51
Figure United States Capacity Utilization Rate of Radiopharmaceuticals 2012-2017	51
Figure United States Sales Revenue (M USD) and Growth Rate of Radiopharmaceuticals 2012-2017	52
Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2012	53
Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2013	54
Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2014	54
Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2015	55
Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2016	55
Figure United States Production Market Share of Major Radiopharmaceuticals Manufacturers in 2017	56
Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2012	56
Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2013	57
Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2014	57
Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2015	58
Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2016	58
Figure United States Sales Market Share of Major Radiopharmaceuticals Manufacturers in 2017	59
Figure United States Sales (M Doses) and Growth Rate of Radiopharmaceuticals 2012-2017	60
Table United States and Major Manufacturers Export of Radiopharmaceuticals 2012-2017 (M Doses)	61
Table United States Supply, Consumption and Gap of Radiopharmaceuticals 2012-2017 (M Doses)	61
Table United States Import, Export and Consumption of Radiopharmaceuticals 2012-2017 (M Doses)	62
Table Price of United States Radiopharmaceuticals Major Manufacturers 2012-2017 (USD/Dose)	62
Table Gross Margin of United States Radiopharmaceuticals Major Manufacturers 2012-2017	62
Table United States and Major Manufacturers Revenue of Radiopharmaceuticals 2012-2017 (M USD)	63
Table United States Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Radiopharmaceuticals 2012-2017	63
Table Bayer Company Profile	64
Figure Radiopharmaceuticals Product Picture of Bayer	65
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bayer (2012-2017)	65
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017	66
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017	66
Table Triad Isotopes Company Profile	67
Figure Radiopharmaceuticals Product Picture of Triad Isotopes	68
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Triad Isotopes (2012-2017)	68
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017	69
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017	69
Table Lantheus Medical Imaging Company Profile	70
Figure Radiopharmaceuticals Product Picture of Lantheus Medical Imaging	71
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Lantheus Medical Imaging (2012-2017)	71
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017	72
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017	72
Table GE Healthcare Company Profile	73
Figure Radiopharmaceuticals Product Picture of GE Healthcare	74
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GE Healthcare (2012-2017)	74
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017	75
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017	75
Table Mallinckrodt Company Profile	76
Figure Radiopharmaceuticals Product Picture of Mallinckrodt	77
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Mallinckrodt (2012-2017)	77
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017	78
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017	78
Table Eli Lilly Company Profile	79
Figure Radiopharmaceuticals Product Picture of Eli Lilly	80
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eli Lilly (2012-2017)	80
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017	81
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017	81
Table Bracco Imaging Company Profile	82
Figure Radiopharmaceuticals Product Picture of Bracco Imaging	83
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bracco Imaging (2012-2017)	84
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017	84
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017	85
Table SIEMENS Company Profile	85
Figure Radiopharmaceuticals Product Picture of SIEMENS	87
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of SIEMENS (2012-2017)	87
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017	88
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017	88
Table Navidea Company Profile	89
Figure Radiopharmaceuticals Product Picture of Navidea	90
Table Radiopharmaceuticals Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Navidea (2012-2017)	90
Figure Radiopharmaceuticals Capacity (M Doses), Production (M Doses) and Growth Rate of 2012-2017	91
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017	91
Table Nordion Company Profile	92
Figure Radiopharmaceuticals Product Picture of Nordion	93
Figure Radiopharmaceuticals Sales (M Doses) and Growth Rate of 2012-2017	93
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017	94
Table IBA Group Company Profile	94
Figure Radiopharmaceuticals Product Picture of IBA Group Healthcare	95
Figure Radiopharmaceuticals Sales (M Doses) and Growth Rate of 2012-2017	96
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017	96
Table Jubilant Pharma Company Profile	97
Table Radiopharmaceuticals Product Picture of Jubilant Pharma	98
Figure Radiopharmaceuticals Sales (M Doses) and Growth Rate of 2012-2017	99
Figure Radiopharmaceuticals Sales (M Doses) and Market Share of 2012-2017	100
Table Radiopharmaceuticals Price by Regions 2012-2017 (USD/Dose)	101
Table Radiopharmaceuticals Price by Companies 2012-2017 (USD/Dose)	101
Table Radiopharmaceuticals Gross Margin by Companies 2012-2017	101
Table Sales Price Comparison of Radiopharmaceuticals by Regions 2012-2017 (USD/Dose)	102
Table Price of Different Radiopharmaceuticals Product Types (USD/Dose)	102
Table Gross Margin of Different Radiopharmaceuticals Applications	103
Figure Marketing Channels Status of Radiopharmaceuticals	104
Table Traders or Distributors of Radiopharmaceuticals with Contact Information	105
Figure Ex-work Price, Channel Price and End Buyer Price of Radiopharmaceuticals (USD/Dose) in 2016	106
Table United States Import, Export of Radiopharmaceuticals (M Doses) 2012-2017	106
Figure United States Capacity (M Doses), Production (M Doses) and Growth Rate of Radiopharmaceuticals 2017-2022	107
Figure United States Capacity Utilization Rate of Radiopharmaceuticals 2017-2022	108
Table United States Radiopharmaceuticals Production by Product Types 2017-2022 (M Doses)	108
Table United States Radiopharmaceuticals Production Market Share by Product Types 2017-2022	108
Figure United States Production Market Share of Radiopharmaceuticals by Type in 2017	109
Figure United States Production Market Share of Radiopharmaceuticals by Type in 2022	110
Figure United States Sales (M Doses) and Growth Rate of Radiopharmaceuticals 2017-2022	111
Figure United States Sales Revenue (Million USD) and Growth Rate of Radiopharmaceuticals 2017-2022	111
Figure United States Sales of Radiopharmaceuticals by Applications 2017-2022 (M Doses)	112
Table United States Production Market Share of Radiopharmaceuticals by Applications 2017-2022	112
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2017	112
Figure United States Production Market Share of Radiopharmaceuticals by Applications in 2022	113
Table United States Production, Import, Export and Consumption of Radiopharmaceuticals 2017-2022 (M Doses)	113
Table United States Production (M Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Radiopharmaceuticals 2017-2022	114
Table Major Raw Materials Suppliers Analysis of Radiopharmaceuticals	115
Table Equipment Suppliers Analysis of Radiopharmaceuticals	116
Table Major Suppliers of Radiopharmaceuticals with Contact Information	116
Table Key Consumers of Radiopharmaceuticals with Contact Information	118
Figure Radiopharmaceuticals Supply Chain Analysis	119
Table New Project SWOT Analysis of Radiopharmaceuticals	120
Table Project Appraisal and Financing	121
Table New Project Construction Period	121
Table New Project Investment Feasibility Analysis of Radiopharmaceuticals	121
Table Research Programs/Design for This Report	124
Figure Bottom-up and Top-down Approaches for This Report	126
Figure Data Triangulation	127
Table Key Data Information from Secondary Sources	128
Table Key Data Information from Primary Sources	129

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $3800
Multi User - US $7600
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify